Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial
Conclusion This randomized double-blind, placebo-controlled clinical trial demonstrated that Amla could reduce frequencies of heartburn and regurgitation and improve heartburn and regurgitation severity in patients with NERD. Trial Registration Iranian Registry of Clinical Trials IRCT2016061428469N1.
Source: Journal of Integrative Medicine - Category: Complementary Medicine Source Type: research
More News: Acid Reflux | Clinical Trials | Complementary Medicine | Endoscopy | Erosive Esophagitis | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Heartburn | Iran Health | Study